EUVIMEDEUVIMED entdecken
Crossref

Structural Modelling and Clinical Interpretation of CDKN1B and CDKN2C Variants in Patients with MEN-like Phenotypes: A Case Series

Nektaria Papadopoulou-Marketou iD, Christina Milou, Eleni Papakonstantinou, Dimitrios Vlachakis, Amalia Sertedaki, Efthymios Poulios, George P Chrousos

Endocrine-Related Cancer · 06.11.2026

DOI: 10.1530/erc-26-0093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, online erschienen am 06.11.2026. Verfasst von Nektaria Papadopoulou-Marketou und 6 weiteren Autor:innen. Beteiligte Einrichtung: ENETS-EURACAN Centre of Excellence for Neuroendocrine Tumours, Endocrinology Unit, 1st Department of Propaedeutic Internal Medicine, Laiko General Ho….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiple endocrine neoplasia (MEN) syndromes involve tumors in multiple endocrine organs. Distinguishing MEN1 from rarer MEN-like syndromes, including MEN4 caused by pathogenic germline CDKN1B variants, can be challenging.

Methods

We describe four individuals from two families, integrating clinical, biochemical and imaging findings with germline whole-exome sequencing, evolutionary conservation, in silico variant-effect prediction, structural modeling and molecular dynamics. Tumor tissue was unavailable for somatic sequencing or loss-of-heterozygosity analysis.

Results

Proband 1, initially suspected of MEN1 because of a nonfunctioning pituitary microadenoma, bilateral adrenal hyperplasia and primary hyperparathyroidism, carried a pathogenic germline CDKN1B frameshift variant, p.Lys96GlnfsTer29. Proband 2 carried the CDKN2C p.Leu107Val variant, classified as a variant of uncertain significance, and had hyperthyroidism, primary hyperaldosteronism, nephrolithiasis, primary hyperparathyroidism, a nonfunctioning pituitary microadenoma and a pancreatic mucinous cystic neoplasm. The variants showed distinct predicted mechanisms. The CDKN1B frameshift preserves the kinase-inhibitory domain but removes the C-terminal regulatory region of p27Kip1 and is predicted to trigger nonsense-mediated decay. In contrast, CDKN2C Leu107 is evolutionarily invariant and buried within the hydrophobic core of ankyrin repeat 4; substitution by valine reduced local hydrophobic packing, consistent with partial destabilization rather than protein loss. The two variant-positive sons of Proband 2 were asymptomatic, and no variant-positive individual carried a MEN1 mutation.

Conclusions

These findings support CDKN1B testing in MEN1-negative patients with MEN features and highlight CDKN2C as a candidate contributor to MEN-like phenotypes. Integrated clinical, genetic, conservation and structural data may support future re-evaluation of p.Leu107Val while preserving its current VUS classification.

Schlagwörter

Stichwörter der Autor:innen

CDKN1BCDKN2CMEN4multiple endocrine neoplasia

Autor:innen und Institutionen

  • ENETS-EURACAN Centre of Excellence for Neuroendocrine Tumours, Endocrinology Unit, 1st Department of Propaedeutic Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens…
  • University Research Institute of Maternal and Child Health and Precision Medicine, and UNESCO Chair on Adolescent Health Care, National and Kapodistrian University of Athens , Athens, Greece.
  • Laboratory of Genetics, Department of Biotechnology, School of Applied Biology & Biotechnology, Agricultural University of Athens , Athens, Greece.
  • Laboratory of Genetics, Department of Medicine, McGill University , Montreal, Quebec, Canada.
  • Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, "Aghia Sophia" Children's Hospital, Medical School, National and Kapodistrian University of Athens , Athens, Greece.
  • 4th Department of Surgery, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens , Chaidari, Greece.

ORCID-Profile: Nektaria Papadopoulou-Marketou

Zitieren

APA

Papadopoulou-Marketou, N., Milou, C., Papakonstantinou, E., Vlachakis, D., Sertedaki, A., Poulios, E., & Chrousos, G. P. (2026). Structural Modelling and Clinical Interpretation of CDKN1B and CDKN2C Variants in Patients with MEN-like Phenotypes: A Case Series. Endocrine-Related Cancer. https://doi.org/10.1530/erc-26-0093

Vancouver

Papadopoulou-Marketou N, Milou C, Papakonstantinou E, Vlachakis D, Sertedaki A, Poulios E, et al. Structural Modelling and Clinical Interpretation of CDKN1B and CDKN2C Variants in Patients with MEN-like Phenotypes: A Case Series. Endocrine-Related Cancer. 2026. doi:10.1530/erc-26-0093

BibTeX
@article{PapadopoulouMarketou2026,
  author = {Papadopoulou-Marketou, Nektaria and Milou, Christina and Papakonstantinou, Eleni and Vlachakis, Dimitrios and Sertedaki, Amalia and Poulios, Efthymios and Chrousos, George P},
  title = {Structural Modelling and Clinical Interpretation of CDKN1B and CDKN2C Variants in Patients with MEN-like Phenotypes: A Case Series},
  journal = {Endocrine-Related Cancer},
  year = {2026},
  doi = {10.1530/erc-26-0093}
}
Kostenlos starten →